To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCAPI1072 | Diphenhydramine HCl (Benadryl) |
Diphenhydramine HCl (Benadryl)
More description
|
|
| DC9834 | Dioscin Featured |
Dioscin(CCRIS 4123; Collettiside III) is a natural steroid saponin derived from several plants, showing potent anti-cancer effect against a variety of tumor cell lines.
More description
|
|
| DC8722 | Dimethoxycurcumin(DiMC) Featured |
Dimethoxycurcumin is an analog of curcumin obtained by methylation of both free phenolic groups in the parent compound.
More description
|
|
| DC10791 | DIM-C-pPhOH(CDIM8) Featured |
DIM-C-pPhOH is a Nur77 Antagonist. DIM-C-pPhOH inhibits lung cancer cell and tumor growth in a metastasis model.
More description
|
|
| DC8274 | Dihydroethidium Featured |
Dihydroethidium(Hydroethidine; PD-MY 003) is a superoxide indicator; exhibits blue-fluorescence in the cytosol until oxidized, where it intercalates within the cell's DNA, staining its nucleus a bright fluorescent red.
More description
|
|
| DC9760 | Dihexa (PNB-0408) Featured |
Dihexa is an oligopeptide drug that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met.
More description
|
|
| DCAPI1032 | Dichlorphenamide (Diclofenamide) Featured |
Dichlorphenamide (Diclofenamide)
More description
|
|
| DCAPI1025 | Dexamethasone Featured |
Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs used as an anti-inflammatory and immunosuppressant.
More description
|
|
| DC11055 | Desmethyl dabrafenib Featured |
Desmethyl dabrafenib (GSK2167542, Dabrafenib metabolite M8) is the desmethyl- metabolic byproduct of Dabrafenib, ameliorates developmental pathologies of Kabuki Syndrome in vivo..
More description
|
|
| DC10458 | Delafloxacin(ABT-492) Featured |
Delafloxacin (RX-3341, ABT-492) is a fluoroquinolone antibiotic agent.
More description
|
|
| DC9337 | Deguelin Featured |
Deguelin, a naturally occurring rotenoid, is known to be an Akt inhibitor and to have an anti-tumor effect on several cancers; decrease levels of phosphorylated Akt.
More description
|
|
| DC11332 | Degarelix (acetate) Featured |
Degarelix is a synthetic gonadotropin-releasing hormone receptor (GNRHR) antagonist (IC50 = 3 nM in HEK293 cells expressing the human receptor).
More description
|
|
| DC4193 | Decitabine Featured |
Decitabine is a potent inhibitor of DNA methylation with IC50 of 438 nM and 4.38 nM in HL-60 and KG1a cells, respectively.
More description
|
|
| DC7398 | DDR1-IN-1 Featured |
DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with IC50/EC50 of 105 nM/87 nM; 4-fold less potent for DDR2 (IC50= 413 nM).
More description
|
|
| DC12554 | DC661 Featured |
DC661 (DC-661) is a novel dimeric chloroquine (CQ) that is capable of deacidifying the lysosome and inhibiting autophagy significantly better than HCQ, targets palmitoyl-protein thioesterase 1 (PPT1).
More description
|
|
| DC21382 | EIDD-1931(NHC) Featured |
EIDD-1931 (β-d-N4-Hydroxycytidine, NHC) inhibits both murine hepatitis virus (MHV) (EC50 of 0.17 μM) and Middle East respiratory syndrome CoV (MERS-CoV) (EC50 of 0.56 μM) with minimal cytotoxicity. It also inhibits SARS-CoV-2 and multiple 2 endemic, epide
More description
|
|
| DC33571 | CAY10566 Featured |
CAY10566 is a potent and selective inhibitor of SCD1 that demonstrates IC50 values of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.
More description
|
|
| DC32353 | Cenicriviroc Mesylate Featured |
Cenicriviroc, also known as TAK-652 and TBR-652, is an experimental drug candidate for the treatment of HIV infection. It is being developed by Takeda Pharmaceutical and Tobira Therapeutics. Cenicriviroc is an inhibitor of CCR2 and CCR5 receptors, allowi
More description
|
|
| DC26133 | Camostat mesylate Featured |
Camostat mesylate is a synthetic, orally bioavailable is a serine protease inhibitor. Used for the treatment of chronic pancreatitis. It attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
More description
|
|
| DC7311 | CC-930(Tanzisertib) Featured |
CC-930(Tanzisertib) is a selective and potent JNK1/JNK2/JNK3(IC50=61/7/6 nM) inhibitor and is currently under clinical development for fibrotic and infammatory indications.
More description
|
|
| DC10574 | CID-25014542 |
CID-25014542 is novel inhibitor of Raf kinases.
More description
|
|
| DC9488 | Cilengitide Featured |
Cilengitide (EMD 121974; NSC 707544) is a potent integrin inhibitor for αvβ3 and αvβ5 integrin with IC50 of 4.1 nM and 79 nM, respectively; ~10-fold selectivity against gpIIbIIIa.
More description
|
|
| DC7602 | DBeQ Featured |
DBeQ is a selective, potent, reversible, and ATP-competitive p97 inhibitor with IC50 of 1.5 μM.
More description
|
|
| DC8826 | DB07268 Featured |
DB07268 is a potent and selective JNK1 inhibitor with an IC50 value of 9 nM.
More description
|
|
| DC3140 | Dasatinib monohydrate Featured |
Dasatinib is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases.
More description
|
|
| DC7395 | Dapivirine Featured |
Dapivirine(TMC 120, TMC 120 R147681) is a NNRTI for HIV reverse transcriptase with IC50 of 24 nM, inhibits a broad panel of HIV-1 isolates from different classes, inclucing a wide range of NNRTI-resistant isolates.
More description
|
|
| DC9259 | DAA1106 Featured |
DAA1106 is a potent and selective ligand for peripheral benzodiazepine receptors, in mitochondrial fractions of the rat brain.
More description
|
|
| DC20219 | D159687 Featured |
D159687 is a selective negative allosteric modulator (NAM) of PDE4D.
More description
|
|
| DC7734 | CZC24832 Featured |
CZC24832 is the first selective PI3Kγinhibitor with IC50 of 27 nM, with 10-fold selectivity over PI3Kβ and >100-fold selectivity over PI3Kα and PI3Kδ.
More description
|
|
| DCAPI1295 | Cytidine |
Cytidine
More description
|
|